Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Slco6c1 Inhibitors

Slco6c1 inhibitors are a class of chemical compounds designed to specifically inhibit the function of solute carrier organic anion transporter family member 6C1 (Slco6c1). Slco6c1 is a member of the SLC family of transporters, which are integral membrane proteins involved in the transport of organic anions and various other molecules across cell membranes. These transporters play crucial roles in maintaining the balance of molecules such as hormones, metabolites, and xenobiotics within and between cells. Slco6c1, like other members of this family, is responsible for the facilitated movement of its specific substrates, and inhibitors that target Slco6c1 are designed to disrupt this process by binding to the transporter, thus blocking its normal function. By interfering with the transport activity of Slco6c1, these inhibitors modulate the flow of substrates that are critical for cellular processes, allowing researchers to study the transporter's specific role in cellular homeostasis.

In the development of Slco6c1 inhibitors, structural biology plays a key role. Researchers study the molecular structure of Slco6c1, often using techniques such as X-ray crystallography or molecular modeling, to identify potential binding sites where inhibitors can effectively interact with the transporter. The design of these inhibitors typically involves optimizing their ability to selectively bind to Slco6c1 without affecting other similar transporters in the SLC family, which requires a deep understanding of the protein's unique structural features. Biochemical assays are employed to evaluate the binding affinity, specificity, and inhibitory effects of these compounds. Through these studies, scientists are able to explore the broader biological functions of Slco6c1 and gain insights into the regulatory mechanisms of organic anion transporters. Understanding the action of Slco6c1 inhibitors contributes to a broader comprehension of solute carrier-mediated transport and its role in maintaining cellular and systemic balance.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Rifampicin, an antibiotic, is known to broadly affect SLCO transporters by inducing their expression, which could indirectly modify SLCO6C1 activity.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporine A, an immunosuppressant, inhibits multiple SLCO transporters, potentially affecting SLCO6C1 function by altering substrate competition.

Gemfibrozil

25812-30-0sc-204764
sc-204764A
5 g
25 g
$66.00
$267.00
2
(2)

Gemfibrozil, a lipid-lowering drug, interacts with various SLCO transporters, possibly influencing SLCO6C1 activity through modulation of lipid metabolism.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$257.00
$505.00
9
(1)

Atorvastatin, a statin, is a substrate for several SLCO transporters, potentially affecting SLCO6C1 by altering transporter availability or specificity.

Indomethacin

53-86-1sc-200503
sc-200503A
1 g
5 g
$29.00
$38.00
18
(1)

Indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), is known to interact with SLCO transporters, which could extend to SLCO6C1, influencing its transport efficiency.

Probenecid

57-66-9sc-202773
sc-202773A
sc-202773B
sc-202773C
1 g
5 g
25 g
100 g
$28.00
$39.00
$100.00
$277.00
28
(2)

Probenecid can inhibit the function of several SLCO transporters, possibly affecting SLCO6C1 by modulating competition for anionic substrates.

Silymarin group, mixture of isomers

65666-07-1sc-301806
50 g
$325.00
(0)

Silymarin, a mixture of flavonolignans from milk thistle, is thought to affect SLCO transporter activity, potentially modulating SLCO6C1 indirectly.

Itraconazole

84625-61-6sc-205724
sc-205724A
50 mg
100 mg
$78.00
$142.00
23
(1)

Itraconazole, an antifungal agent, has been shown to inhibit several SLCO transporters, which might include SLCO6C1, affecting its function.

Erythromycin

114-07-8sc-204742
sc-204742A
sc-204742B
sc-204742C
5 g
25 g
100 g
1 kg
$57.00
$245.00
$831.00
$1331.00
4
(3)

Erythromycin, an antibiotic, interacts with SLCO transporters, potentially modulating SLCO6C1 activity through competition or inhibition.

Nelfinavir

159989-64-7sc-507314
10 mg
$168.00
(0)

Nelfinavir, an antiretroviral drug, has been reported to inhibit SLCO transporter activity, which could affect SLCO6C1 indirectly.